Literature DB >> 18434602

A novel role for Cdk1/cyclin B in regulating B-raf activation at mitosis.

Sergiy I Borysov1, Thomas M Guadagno.   

Abstract

MAPK activity is important during mitosis for spindle assembly and maintenance of the spindle checkpoint arrest. We previously identified B-Raf as a critical activator of the MAPK cascade during mitosis in Xenopus egg extracts and showed that B-Raf activation is regulated in an M-phase-dependent manner. The mechanism that mediates B-Raf activation at mitosis has not been elucidated. Interestingly, activation of 95-kDa B-Raf at mitosis does not require phosphorylation of Thr-599 and Ser-602 residues (Thr-633 and Ser-636 in Xenopus B-Raf), previously shown to be essential for B-Raf activation by Ras. Instead, we provide evidence for Cdk1/cyclin B in mediating mitotic activation of B-Raf. In particular, Cdk1/cyclin B complexes associate with B-Raf at mitosis in Xenopus egg extracts and contribute to its phosphorylation. Mutagenesis and in vitro kinase assays demonstrated that Cdk1/cyclin B directly phosphorylates B-Raf at Serine-144, which is part of a conserved Cdk1 preferential consensus site (S(144)PQK). Importantly, phosphorylation of Ser-144 is absolutely required for mitotic activation of B-Raf and subsequent activation of the MAPK cascade. However, substitution of a phospho-mimicking amino acid at Ser-144 failed to produce a constitutive active B-Raf indicating that, in addition of Ser-144 phosphorylation, other regulatory events may be needed to activate B-Raf at mitosis. Taken together, our data reveal a novel cell cycle mechanism for activating the B-Raf/MEK/MAPK cascade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434602      PMCID: PMC2441668          DOI: 10.1091/mbc.e07-07-0679

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  48 in total

1.  Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.

Authors:  C S Mason; C J Springer; R G Cooper; G Superti-Furga; C J Marshall; R Marais
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

2.  B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms.

Authors:  Nancy H Tran; Xiaochong Wu; Jeffrey A Frost
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

3.  Mechanistic studies of the mitotic activation of Mos.

Authors:  Jianbo Yue; James E Ferrell
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  B-Raf is critical for MAPK activation during mitosis and is regulated in an M phase-dependent manner in Xenopus egg extracts.

Authors:  Sergiy I Borysov; Anthony W M Cheng; Thomas M Guadagno
Journal:  J Biol Chem       Date:  2006-06-08       Impact factor: 5.157

5.  Mps1 phosphorylation by MAP kinase is required for kinetochore localization of spindle-checkpoint proteins.

Authors:  Yong Zhao; Rey-Huei Chen
Journal:  Curr Biol       Date:  2006-09-05       Impact factor: 10.834

6.  Cyclin B/cdc2 induces c-Mos stability by direct phosphorylation in Xenopus oocytes.

Authors:  A Castro; M Peter; L Magnaghi-Jaulin; S Vigneron; S Galas; T Lorca; J C Labbé
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

7.  MEK kinase activity is not necessary for Raf-1 function.

Authors:  M Hüser; J Luckett; A Chiloeches; K Mercer; M Iwobi; S Giblett; X M Sun; J Brown; R Marais; C Pritchard
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

8.  Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx.

Authors:  Susan Walsh; Seth S Margolis; Sally Kornbluth
Journal:  Mol Cancer Res       Date:  2003-02       Impact factor: 5.852

Review 9.  Mechanisms of regulating the Raf kinase family.

Authors:  Huira Chong; Haris G Vikis; Kun-Liang Guan
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

10.  Active cyclin B1-Cdk1 first appears on centrosomes in prophase.

Authors:  Mark Jackman; Catherine Lindon; Erich A Nigg; Jonathon Pines
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

View more
  6 in total

1.  Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors.

Authors:  Sergiy I Borysov; Antoneta Granic; Jaya Padmanabhan; Claire E Walczak; Huntington Potter
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

Review 2.  CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Authors:  Paul Dent; Yong Tang; Adly Yacoub; Yun Dai; Paul B Fisher; Steven Grant
Journal:  Mol Interv       Date:  2011-04

3.  High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888.

Authors:  Susan K Lyman; Suzanne C Crawley; Ruoyu Gong; Joanne I Adamkewicz; Garth McGrath; Jason Y Chew; Jennifer Choi; Charles R Holst; Leanne H Goon; Scott A Detmer; Jana Vaclavikova; Mary E Gerritsen; Robert A Blake
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

4.  A MEK-independent role for CRAF in mitosis and tumor progression.

Authors:  Ainhoa Mielgo; Laetitia Seguin; Miller Huang; Maria Fernanda Camargo; Sudarshan Anand; Aleksandra Franovic; Sara M Weis; Sunil J Advani; Eric A Murphy; David A Cheresh
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

5.  Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells.

Authors:  Masahiro Shimizu; Hiroshi Shibuya; Nobuyuki Tanaka
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

6.  Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles.

Authors:  Anja E Eisenhardt; Adrian Sprenger; Michael Röring; Ricarda Herr; Florian Weinberg; Martin Köhler; Sandra Braun; Joachim Orth; Britta Diedrich; Ulrike Lanner; Natalja Tscherwinski; Simon Schuster; Nicolas Dumaz; Enrico Schmidt; Ralf Baumeister; Andreas Schlosser; Jörn Dengjel; Tilman Brummer
Journal:  Oncotarget       Date:  2016-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.